Welcome to MyStrategist, an online experience like no other in the medical device industry.

MedTech Strategist, the industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today .

Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Business Strategies

IDbyDNA Beyond COVID-19: Revolutionizing Microbiology through Metagenomics

IDbyDNA is "democratizing" the emerging field of metagenomics by marrying genomic sequencing with state-of-the-art computational sciences to bring rapid, cost-effective precision medicine to infectious disease testing. An example of its potential: rapid characterization of the SARS-CoV-2 virus.

Virtual Investment & Partnering Summit 2020 registration is now open. On-Demand October 15th – November 20th this year's most anticipated global event will sell out. Register Today!

Register   Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.


Business Strategies

The Paclitaxel Drug-Coated Device Controversy: Case Closed?

New data presented at this year’s virtual TCT conference could help put to rest safety fears around the use of paclitaxel coated devices in the peripheral vasculature. That’s good news for medtech companies eager for a market recovery.

Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
More From MedTech Strategist: